A cancer vaccine for free, courtesy Russia

A Cure for Cancer? Russia’s 2024 Vaccine Sparks Hope
Russian experts claim to have developed a mRNA-based vaccine to treat cancer, which will be available for free to patients from early 2025.
Vaccine for cancer? Russia unveils breakthrough mRNA vaccine, to be available in 2025 for free
Russia has developed a groundbreaking mRNA cancer vaccine, set for public release in 2025. The vaccine, which will be distributed free of charge, has shown promising results in pre-clinical trials, preventing tumour growth and spread.
Free cancer treatment? Russia's mRNA vaccine sparks hope for a breakthrough cure
Russia unveils a groundbreaking mRNA cancer vaccine, personalized & using AI, aiming for public availability by 2025.
Russia Develops New MRNA Cancer Vaccine, Set For Free Distribution By 2025
Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025.
Russia claims breakthrough in cancer treatment with mRNA vaccine, free for patients by 2025
Russia has announced the development of an mRNA cancer vaccine, leveraging AI and pre-clinical success in suppressing tumors and preventing metastases.
Russia To Launch Free Cancer Vaccine in 2025
The Russian Ministry of Health claims it will begin distributing vaccinations against cancer as soon as early 2025.
Russia announces development of free cancer vaccine amid skepticism
Russia said it has developed a cancer vaccine that will be distributed to Russian patients for free starting in early 2025 — but the news has drawn skepticism. Andrey Kaprin, the general director of the Radiology Medical Research Center of the Russian Ministry of Health,
This country to offer free personalized cancer vaccines to all citizens in 2025
Russia claims to have developed a new mRNA vaccine for cancer treatment. The Russian Ministry of Health — as reported by the state-owned news agency TASS — has declared that a cancer vaccine will be provided at no cost to Russian patients from the beginning of 2025.
Russian Cancer Vaccine: Scientists 'Very Skeptical'
As Russia announces a new vaccine against cancer, scientists tell Newsweek they remain skeptical until the research is published.
Russia To Launch Cancer Vaccines By 2025 For Free Of Cost: Report
Russia has claimed to have developed its own mRNA vaccine against cancer, which it plans to launch for the general public in early 2025, reported TASS news agency. The vaccine will be distributed free of cost to patients,
Russia Announces Plans to Release Cancer Vaccine in 2025
Russia's Health Ministry says it has developed a cancer vaccine that they plan to distribute free of charge to some of the country's citizens.
New Scientist2d
Will an mRNA vaccine target the norovirus strain behind surging cases?
A new type of norovirus is causing a very high number of cases in countries like England, just as a large trial of an mRNA ...
Australia’s first mRNA Covid vaccine candidate could solve ‘immune imprinting’ problem — here’s what that could mean
Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the one of the biggest problems with ...
FierceBiotech4d
mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain
As human cases of avian influenza slowly tick up amid the outbreak in U.S. dairy cattle, the Centers for Disease Control and ...
Medscape9d
Self-Replicating mRNA Vaccine for COVID Prevention
Europe has approved two drugs for preventing COVID-19 infection: a monoclonal antibody and a self-amplifying mRNA vaccine.
Senders Pediatrics seeks participants, ages 10-21, for Epstein-Barr virus vaccine clinical trial
The Eclipse Trial is researching an investigational vaccine to protect against Epstein-Barr virus (EBV) and infectious ...
Becker's Hospital Review5d
FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates
The FDA has granted fast track designation to two combination vaccine candidates that aim to protect adults 50 and older from both influenza and COVID-19, according to a Dec. 16 AJMC report. These ...
Medscape4d
RSV Vaccine Research in Infants May Proceed With Caution
In this population, 12.5% of infants who received an mRNA vaccine developed clinically significant/severe RSV compared ...
infectiousdiseaseadvisor.com6d
Original mRNA COVID-19 Vaccine Series Effective Against VTE-Related Hospitalization
Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.